Understanding Hodgkins Lymphoma

Hodgkin's lymphoma (also known as Hodgkin's disease) is a type of cancer that affects the lymphatic system and originates from B cells, which are important components of our immune system responsible for the memory and development of antibodies.

Who Does Hodgkin's Lymphoma Affect?

Hodgkin's lymphoma has a bimodal distribution, meaning it has two peak age groups when it most commonly occurs:

• Young adults between 20 to 30 years old (25)
• Older adults between 55 to 65 years old (60)

Recognizing the Signs and Symptoms

Patients with Hodgkin's lymphoma typically present with lymphadenopathy (enlarged lymph nodes), most commonly in the neck and mediastinum (chest). Additionally, many patients experience "B symptoms" or constitutional symptoms, including:

• Unexplained fever
• Drenching night sweats
• Unintentional weight loss (typically more than 10% of body weight)
• Pruritus (persistent itching)

These symptoms occur because the lymphoma affects the body's immune system and can trigger systemic inflammation.

Laboratory Findings

Blood tests in patients with Hodgkin's lymphoma often reveal several characteristic patterns:

• Normal/elevated white blood cell (leukocyte) count
• Lymphopenia
  • Lymphocyte-depleted subtype
• Eosinophilia
  • Tumor cells secrete cytokines that generate eosinophils
• Anemia (low red blood cell count)
  • Anemia of chronic disease due to chronic inflammation
• Elevated ESR (erythrocyte sedimentation rate)
• Increased ferritin concentration
  • Acute phase reactant, as well as anemia of chronic disease
• Elevated LDH

These changes are typically caused by the underlying systemic inflammation that the lymphoma creates throughout the body.

Diagnosis: From Imaging to Biopsy

The diagnostic process typically follows a systematic approach:

Initial Evaluation: Chest X-rays or CT scans to identify enlarged lymph nodes and assess the extent of the disease.

Definitive Diagnosis: The gold standard for diagnosing Hodgkin's lymphoma is an excisional lymph node biopsy, where an entire lymph node is surgically removed and examined under a microscope.

What Makes It Hodgkin's: The biopsy will reveal several distinctive features:

• Reed-Sternberg cells with characteristic "owl's eye" inclusions
• Large inflammatory infiltrate with predominantly eosinophils (a type of white blood cell)
• Areas of fibrosis (scar tissue)
• Hodgkin cells that are typically CD15- and CD30+ (specific protein markers)

Subtypes and Prognosis

Hodgkin's lymphoma has several subtypes, with nodular sclerosis being the most common. The lymphocyte-depleted subtype tends to have a more challenging prognosis.

Treatment Approaches

Treatment for Hodgkin's lymphoma typically involves a combination of:

• Chemotherapy: Medications that target and destroy cancer cells
• Radiation therapy: High-energy beams directed at affected areas